4-(3-(bis(beta-hydroxyphenethyl)amino)butyl)benzamide: structure given in first source; RN given is for parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 146200 |
| SCHEMBL ID | 6406551 |
| MeSH ID | M0132533 |
| Synonym |
|---|
| ro-16-8714 |
| 4-[3-[bis(2-hydroxy-2-phenylethyl)amino]butyl]benzamide |
| 4-(3-(bis(beta-hydroxyphenethyl)amino)butyl)benzamide |
| 90505-66-1 |
| benzamide, 4-(3-(bis(2-hydroxy-2-phenylethyl)amino)butyl)-, stereoisomer |
| ro 16-8714 |
| SCHEMBL6406551 |
| 4-{3-[bis(2-hydroxy-2-phenylethyl)amino]butyl}benzamide |
| DTXSID40920354 |
| AKOS040749317 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.75) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (30.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (70.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||